Refine by
Harvesting Articles & Analysis
45 news found
ImmunAdd, a privately held pharmaceutical company developing a fully synthetic, rationally designed, saponin-based small molecule vaccine adjuvant, attended the Vaccines Summit 2022 in Washington DC on October 11-13. Founder of ImmunAdd, Pi-Hui Liang, said “My team and I were delighted to attend the Vaccines Summit, an internationally renowned academic conference, where we presented a ...
In view of the ample advantages, BOC Sciences' technical team started their project of developing a comprehensive stable isotope labeling platform at an early stage, which has harvested numerous fruits -- a long list of isotope labeled compounds covering the most market needs. ...
The peer-reviewed article published in the journal Frontiers in Oncology (article), shows that the prostate cancer test based on CTC harvested with the ISET® technology and identified by the Immuno-Cytochemistry (ICC) PSA marker has an estimated positive-predictive-value (PPV) of 99% and negative-predictive-value (NPV) of 97%, providing a more reliable screening test for ...
Tamminga’s publication demonstrates the exceptional performance of the ISET technology to harvest CTC from DLA products. It opens the way to new CTC-based approaches to treat and follow-up patients with NSCLC and with other types of cancers. ...
ImmunAdd’s next-generation Saponin-based adjuvant IA-05 induced both humoral and cellular immunities in various vaccines, including those against COVID-19, influenza, and cancer. IA-05 is accessible via total chemical synthesis and does not rely on extracts from Quillaja Saponaria or any other tree. ImmunAdd is undertaking the development of IA-05 in collaboration with several biopharma ...
About ImmCelz ImmCelz®, which is protected by trade secrets and published U.S. patents, utilizes adult stem cells derived from qualified donors to endow specific properties to the patient's immune cells. After the patient's harvested cells are incubated with the Company's cell-free reprogramming "cocktail", the cells are re-injected back into the patient. ...
My hope is that AuriNovo™ will one day become the standard-of-care replacing the current surgical methods for ear reconstruction requiring the harvesting of rib cartilage or the use of porous polyethylene (PPE) implants. ...
Financial Highlights and Recent Updates: Reported commercial revenue, which excludes BARDA revenue, of $7.4 million a 61% increase compared to $4.6 million in the corresponding period in the prior year Reported total revenue, which includes BARDA revenue, of $7.5 million compared to $8.8 million in the corresponding period in the prior year, which included $4.1 million in BARDA revenue In ...
Wines, for instance, if they are not ecologically sourced, might contain sulfites, a preservative that grape growers dust over grapes in the weeks leading up to harvest. Sulfites can trigger allergy-like reactions to sensitized people, such as wheezing in those suffering from asthma, allergic rhinitis, and urticaria[3]. ...
Healthcare professionals should read the INSTRUCTIONS FOR USE - RECELL® Autologous Cell Harvesting Device (https://recellsystem.com/) for a full description of indications for use and important safety information including contraindications, warnings, and precautions. ...
About ImmCelz ImmCelz®, which is protected by trade secrets and published U.S. patents, utilizes adult stem cells derived from qualified donors to endow specific properties to the patient's immune cells. After the patient's harvested cells are incubated with the Company's cell-free reprogramming "cocktail", the cells are re-injected back into the patient. ...
He has also held a number of other senior level positions with companies in the global ingredient space including Sweet Harvest Foods and Kerry Inc., among others. -- About Arzeda Arzeda harnesses the power of computation to create and manufacture proteins that enhance our lives and protect our planet. ...
ByArzeda
ImmCelz®, which is protected by trade secrets and published U.S. patents, utilizes adult stem cells derived from qualified donors to endow specific properties to the patient's immune cells. After the patient's harvested cells are incubated with the Company's cell-free reprogramming "cocktail", the cells are re-injected back into the patient. ...
(NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that an abstract highlighting the clinical trial protocol utilizing the RECELL® Autologous Cell Harvesting Device (RECELL® System) to treat vitiligo will be ...
“This most recent action by CMS further represents its commitment to improving the way ischemic heart failure is treated and is supportive of BioCardia’s therapeutic investigational product candidates furnished by a comprehensive approach to bone marrow cell harvest, processing, and delivery in a single procedure,” commented Peter Altman, Ph.D., ...
” After the procedure, Sheldon felt great and was able to leave the hospital the same day, and a few days later was back on his tractor, helping his sons with the harvest. He is looking forward to the peace of mind of not having to worry about the risk of stroke or bleeding. ...
It is designed to overcome the limitations and complications resulting from patient’s vein harvesting, which is the current option in CABG surgery. Around one million patients undergo CABG surgery each year. ...
Jignesh Uteshiya, Director Uteshiya Medicare, said, “We are excited to have partnered with Healthium Medtech and look forward to manufacturing their patented arthroscopy portfolio in a completely green facility built using recycled materials, with built-in energy efficient systems, rainwater harvesting and onsite renewable energy generation. We are also optimizing and ...
The publication provides detailed analysis of a tendon biopsy taken from a 66-year-old patient 10 weeks after his own stem cells were harvested and injected into his damaged shoulder tendon using InGeneron’s Transpose® RT System. ...
About Aker BioMarine ASA Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®), aquaculture (QRILL® Aqua), and animal feed applications (QRILL® Pet), including INVI™, ...